Security authority launches tender for DNA laboratory supplies
Framework tender will secure specialised reagents and consumables for human genetic analysis in a forensic DNA laboratory, reflecting rising demand for such kits.
Framework tender will secure specialised reagents and consumables for human genetic analysis in a forensic DNA laboratory, reflecting rising demand for such kits.
Follow Tenderlake on LinkedIn for concise insights on public-sector tenders and emerging procurement signals.
On 21st April 2026, Jefatura de Asuntos Económicos de la Guardia Civil published a contract notice for a new framework agreement to supply the DNA laboratory, covering the provision of various materials and reagents for human genetic analysis in the DNA Laboratory of the Criminalistics Service of the Civil Guard. The notice underlines how modern forensic work depends on the same specialised supply chains that serve hospitals, universities and research institutes.
The contract notice sets out a clear objective: the framework agreement will regulate the supply of various laboratory materials and reagents for human genetic analysis in the Civil Guard’s DNA Laboratory. Rather than a broad scientific remit, the focus is explicitly on human genetics in a criminalistics context.
The description suggests a wide range of consumables, from basic laboratory materials to specialist genetic reagents. Although the list of products is not detailed in the summary, comparable tenders point to the kinds of items commonly required for this sort of work. In February 2026, Krajské ředitelství policie Královéhradeckého kraje published a framework agreement for DNA consumables covering quantification, amplification and isolation steps in criminal expert examinations. That police tender highlights how forensic DNA laboratories draw on a mix of reagents and plastics tailored to the full workflow of genetic profiling.
By anchoring its framework in “human genetic analysis”, the Civil Guard aligns its laboratory more closely with the techniques used in clinical genetics and genomics. The notice points to an operational environment in which criminalistics must keep pace with advances in human DNA analysis if it is to remain effective.
The decision to use a framework agreement rather than a one-off supply contract places the Civil Guard alongside a long list of laboratories that now procure their consumables through multi-use arrangements. In November 2025, Spitalul Judetean de Urgenta Piatra Neamt issued a framework agreement for hospital laboratory reagents with a maximum of three economic operators, and with subsequent contracts awarded according to departmental requests and budget availability. That structure shows how frameworks are being used to handle fluctuating demand while keeping a grip on supplier numbers.
Research and specialist labs are taking a similar approach. In January 2026, the Institute of Applied Biotechnologies a.s. launched a laboratory materials framework covering kits, chemicals and plastics to meet the needs of specific projects. The wording underlines how frameworks can be aligned to project cycles as well as to routine operations.
Other buyers emphasise the complexity of their requirements. In April 2026, Institut Scientifique de Service Public published a framework agreement for laboratory products that spans chemicals, consumables and equipment, divided into multiple lots with specific requirements for bidders. A month earlier, Spitalul Municipal Odorheiu Secuiesc had gone to market for a 16-lot framework for laboratory reagents, with detailed product descriptions and quantities held in the specifications.
Several hospital notices from March 2026, including a framework for reagents at Spitalul Judetean de Urgenta Valcea, stress compatibility with specific analysers and testing systems, as well as minimum and maximum quantities per lot. Together, these examples show why laboratories with ongoing DNA workloads are gravitating towards frameworks: they need a contractual mechanism that can cope with technical detail, varying volumes and equipment-specific consumables.
The Civil Guard’s DNA Laboratory is far from alone in seeking stable access to human genetic analysis tools. In April 2026, Tartu Ülikool advertised a framework for genomics laboratory supplies at its Genomics Institute, focused on reagents and tools for sequencing library preparation, including next-generation sequencing (NGS) libraries and PCR. On the same month, KB Dubrava went to market for molecular diagnostics reagents for nucleic acid isolation, PCR, qPCR, dPCR and NGS in its Clinical Institute for Laboratory Diagnostics.
Earlier in February 2026, Université de Liège issued a framework for molecular biology products, concentrating on DNA extraction and purification kits alongside experimental RNA reagents. These contracts show university and clinical laboratories locking in supplies for the same core techniques that underpin forensic human genetic analysis.
Medical buyers are also using frameworks to support genetic disease programmes. In March 2026, the Sf. Maria Emergency Clinical Hospital for Children in Iasi launched a framework agreement for reagents, consumables and laboratory materials to support a Women’s and Children’s Health Programme focused on preventing genetic diseases. Meanwhile, Spitalul Judetean de Urgenta Calarasi “Dr. POMPEI SAMARIAN” is seeking diagnostic reagents compatible with equipment for nosocomial infection testing, blurring the line between microbiology, infection control and molecular methods.
Biomedical research foundations are another prominent buyer group. In December 2025, the Foundation for Biomedical Research of Puerta de Hierro Hospital set up a framework for supply of laboratory reagents, spanning sanitary materials, antibodies, reagents and animal care materials. Two months later, the Foundation for Biomedical Research of Gregorio Marañón Hospital followed with a laboratory supplies framework that covers chemical materials, general laboratory items, medical supplies, antibodies, genetic reagents, cell culture reagents, immunodetection reagents and animal care materials.
Against this backdrop, the Civil Guard’s DNA Laboratory sits within a crowded market where law enforcement, healthcare providers, universities and research institutes are all sourcing overlapping sets of genetic and molecular biology consumables. The new framework will draw forensic purchasing into that wider ecosystem.
The summary of the Civil Guard notice is concise. It confirms a framework agreement, a focus on “various laboratory materials and reagents”, and a clear application area: human genetic analysis in the DNA Laboratory of the Criminalistics Service. It does not, however, spell out product lists, lot structures or any limits on the number of suppliers, so those details will sit in the full tender documentation.
Across the recent laboratory frameworks, several themes recur. Buyers often organise their purchases into multiple lots, as seen at Institut Scientifique de Service Public and Spitalul Municipal Odorheiu Secuiesc. They tend to specify compatibility with installed analysers and testing systems, as in the Valcea and Calarasi hospital notices. And they increasingly group genetic reagents with wider laboratory and animal care materials, as the Puerta de Hierro and Gregorio Marañón research foundations have done.
For those tracking public-sector demand for human genetic analysis, the Civil Guard’s forensic DNA framework is another data point in a steady flow of laboratory tenders published from November 2025 through April 2026. Future notices will show whether law enforcement continues to align its DNA laboratory procurement with the patterns already visible in healthcare, university and research settings.
Follow Tenderlake on LinkedIn for concise insights on public-sector tenders and emerging procurement signals.